Statement - Implementation of CETA

Friday, September 22, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

OTTAWA, Sept. 21, 2017 /CNW/ -With regards to the provisional application of the Comprehensive and Economic Trade Agreement

(CETA), Pamela Fralick, President, Innovative Medicines Canada issued the following statement:

"Innovative Medicines Canada welcomes the implementation of the Comprehensive and Economic Trade Agreement (CETA) between

Canada and the European Union.

The Canadian life science sector will benefit from the improvements of Canada's intellectual property provisions that are now closer to the level of its major trading partners. Improving our intellectual property regime is one essential component of allowing Canada's bio-sciences sector to continue to grow and provide high-quality jobs to Canadians, attracting investment in research and development and finding the next generation of medicines.

Canada has made a significant step to provide innovators with some compensation for delays in obtaining marketing approval for pharmaceuticals. However, the regulations have also substantially changed Canada's patent linkage system in a manner not required by CETA, and these changes create additional commercial uncertainty for innovators. Innovative Medicines Canada will continue to work with governments to support the Canadian life sciences environment and to develop solutions that achieve equitable and timely access to new medicines in Canada."

ABOUT INNOVATIVE MEDICINES CANADA

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

SOURCE Innovative Medicines Canada



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook